6-[(3,5-dimethyl-1H-pyrazol-4-yl)methyl]-5-[(4R)-4-hydroxyisoxazolidine-2-carbonyl]-1-isobutyl-3-methyl-thieno[2,3-d]pyrimidine-2,4-dione

ID: ALA5221129

Chembl Id: CHEMBL5221129

PubChem CID: 156899746

Max Phase: Preclinical

Molecular Formula: C21H27N5O5S

Molecular Weight: 461.54

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1n[nH]c(C)c1Cc1sc2c(c1C(=O)N1C[C@@H](O)CO1)c(=O)n(C)c(=O)n2CC(C)C

Standard InChI:  InChI=1S/C21H27N5O5S/c1-10(2)7-25-20-17(18(28)24(5)21(25)30)16(19(29)26-8-13(27)9-31-26)15(32-20)6-14-11(3)22-23-12(14)4/h10,13,27H,6-9H2,1-5H3,(H,22,23)/t13-/m1/s1

Standard InChI Key:  ISIVOJWVBJIOFM-CYBMUJFWSA-N

Alternative Forms

  1. Parent:

    ALA5221129

    ---

Associated Targets(non-human)

Slc16a1 Monocarboxylate transporter 1 (151 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc16a7 Monocarboxylate transporter 2 (30 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 461.54Molecular Weight (Monoisotopic): 461.1733AlogP: 1.10#Rotatable Bonds: 5
Polar Surface Area: 122.45Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.92CX Basic pKa: 3.89CX LogP: 1.53CX LogD: 1.53
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.59Np Likeness Score: -1.04

References

1. Wang Y, Qin L, Chen W, Chen Q, Sun J, Wang G..  (2021)  Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1.,  226  [PMID:34517305] [10.1016/j.ejmech.2021.113806]
2. Puri S, Juvale K..  (2020)  Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights.,  199  [PMID:32388280] [10.1016/j.ejmech.2020.112393]

Source